Levodropropizine (Standard)
Based on 1 Customer Validation
Levodropropizine (Standard) is the analytical standard of Levodropropizine. This product is intended for research and analytical applications. Levodropropizine (DF-526) is an orally active histamine receptor inhibitor, Levodropropizine is an effective and very well tolerated peripheral antitussive agent.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza: 99.78%
- No. CAS: 99291-25-5
- Fòrmula: C13H20N2O2
- Peso molecular:236.31
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureza y Documentación
-
Help & FAQs
-
HY-B1895
Levodropropizine
-
HY-10585A
Valproic acid sodium
-
HY-B0801A
Fexofenadine hydrochloride
-
HY-13511A
Rupatadine Fumarate
-
HY-B0559
Nabumetone
-
HY-A0069
Doxylamine succinate
-
HY-B1510
Acrivastine
-
HY-B1589A
Carbinoxamine maleate salt
-
HY-B0814
Levocetirizine
-
HY-13511AR
Rupatadine Fumarate (Standard)
-
HY-10585AG
Valproic acid sodium (GMP)
-
HY-10585AR
Valproic acid sodium (Standard)
Product Information
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
No. CAS 99291-25-5
-
Appearance Solid
-
Peso molecular 236.31
-
Fòrmula C13H20N2O2
-
Color White to off-white
-
SMILES
OC[C@@H](O)CN1CCN(C2=CC=CC=C2)CC1
-
Synonyms
(S)-(-)-Dropropizine (Standard); DF-526 (Standard)
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
[1]. Zanasi A, et al. Levodropropizine for treating cough in adult and children: a meta-analysis of published studies. Multidiscip Respir Med. 2015 May 31;10(1):19. [Content Brief]
[2]. Luo YL, et al. Effects of four antitussives on airway neurogenic inflammation in a guinea pig model of chronic cough induced by cigarette smoke exposure. Inflamm Res. 2013 Dec;62(12):1053-61. [Content Brief]
[3]. Erdogan MA, et al. Levodropropizine suppresses seizure activity in rats with pentylenetetrazol-induced epilepsy. Epilepsy Res. 2019 Feb;150:32-37. [Content Brief]
[4]. Yamawaki I, et al. Levodropropizine reduces capsaicin- and substance P-induced plasma extravasation in the rat trachea. Eur J Pharmacol. 1993 Oct 12;243(1):1-6. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Levodropropizine (Standard) Related Classifications
HY-B1895R Related Classifications
Powered by Bioz